Fetal neuroprotection by magnesium sulfate: from translational research to clinical application
Despite improvements in perinatal care, preterm birth still occurs regularly and the
associated brain injury and adverse neurological outcomes remain a persistent challenge …
associated brain injury and adverse neurological outcomes remain a persistent challenge …
Magnesium sulfate and fetal neuroprotection: overview of clinical evidence
Antenatal administration of magnesium sulfate is an important part of the neuroprotective
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …
strategy for preterm infants. Strong evidence from five randomized controlled trials and five …
Neuroprotection in preterm infants
R Berger, S Söder - BioMed research international, 2015 - Wiley Online Library
Preterm infants born before the 30th week of pregnancy are especially at risk of perinatal
brain damage which is usually a result of cerebral ischemia or an ascending intrauterine …
brain damage which is usually a result of cerebral ischemia or an ascending intrauterine …
Antenatal magnesium sulfate: neuro-protection for preterm infants
S Oddie, DJ Tuffnell, W McGuire - … of Disease in Childhood-Fetal and …, 2015 - fn.bmj.com
The neuro-protective effect of antenatal magnesium sulfate on very preterm infants has been
demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium …
demonstrated in good-quality randomised controlled trials and meta-analyses. Magnesium …
Antenatal magnesium sulfate for fetal neuroprotection: a critical appraisal and systematic review of clinical practice guidelines
PM Jayaram, MK Mohan, I Farid… - Journal of perinatal …, 2019 - degruyter.com
Background Magnesium sulfate is an accepted intervention for fetal neuroprotection. There
are some perceived differences in the international recommendations on the use …
are some perceived differences in the international recommendations on the use …
Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants
PE Bouet, S Brun, H Madar, AL Baisson, V Courtay… - Scientific Reports, 2015 - nature.com
The aim of our study was to assess the feasibility of implementing a protocol for the use of
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …
The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection
Y Jacquemyn, A Zecic, D Van Laere… - Archives of gynecology …, 2015 - Springer
Purpose To review the effect of intravenous magnesium in obstetrics on fetal/neonatal
neuroprotection. Methods A systematic review of published studies. Results Five …
neuroprotection. Methods A systematic review of published studies. Results Five …
Barriers and enablers to implementing antenatal magnesium sulphate for fetal neuroprotection guidelines: a study using the theoretical domains framework
E Bain, T Bubner, P Ashwood, E Van Ryswyk… - BMC pregnancy and …, 2015 - Springer
Background Strong evidence supports administration of magnesium sulphate prior to birth at
less than 30 weeks' gestation to prevent very preterm babies dying or developing cerebral …
less than 30 weeks' gestation to prevent very preterm babies dying or developing cerebral …
Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention
KJ Gibbins, KR Browning, VV Lopes… - Obstetrics & …, 2013 - journals.lww.com
OBJECTIVE: Clinical trials support the efficacy and safety of magnesium sulfate for cerebral
palsy prevention. We evaluated the implementation of a clinical protocol for the use of …
palsy prevention. We evaluated the implementation of a clinical protocol for the use of …
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
C Chollat, L Le Doussal, G de La Villéon… - BMC Pregnancy and …, 2017 - Springer
Abstract Background Magnesium sulphate (MgSO 4) is the only treatment approved for fetal
neuroprotection. No information on its use is available in the absence of a national registry …
neuroprotection. No information on its use is available in the absence of a national registry …